Engineered immune cells take on recurrent brain tumors
Disease control
Not yet recruiting
This early-phase trial tests a new treatment for people whose malignant glioma (a type of brain cancer) has come back. The therapy uses the patient's own immune cells, modified to recognize and attack the cancer while also blocking a tumor defense mechanism. The study will enroll…
Phase: PHASE1 • Sponsor: Ming Yang • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC